121 related articles for article (PubMed ID: 2228021)
1. Evidence of a role for TNF-alpha in cytolysis by CD4+, class II MHC-restricted cytotoxic T cells.
Tite JP
Immunology; 1990 Oct; 71(2):208-12. PubMed ID: 2228021
[TBL] [Abstract][Full Text] [Related]
2. CD4-class II major histocompatibility complex interaction does not enhance killing by a class I-restricted CD4+CD8+ cytotoxic T cell clone.
McAdam AJ; Blieden TM; Frelinger JG; Lord EM
Eur J Immunol; 1992 Sep; 22(9):2461-4. PubMed ID: 1516633
[TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex class II-restricted cytotoxicity by self-myelin basic protein-reactive T-cell hybridomas: evidence for a tumour necrosis factor-independent nucleolytic mechanism.
Rayner DC; Petrycky-Cox LD; Diocee M; Rector E
Immunology; 1993 Feb; 78(2):273-8. PubMed ID: 7682537
[TBL] [Abstract][Full Text] [Related]
4. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
Yoshimura A; Shiku H; Nakayama E
J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
[TBL] [Abstract][Full Text] [Related]
5. Evidence for tumor necrosis factor-alpha involvement in the optimal induction of class I allospecific cytotoxic T cells.
Robinet E; Branellec D; Termijtelen AM; Blay JY; Gay F; Chouaib S
J Immunol; 1990 Jun; 144(12):4555-61. PubMed ID: 2161875
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor activity of class II MHC antigen-restricted cloned autoreactive T cells. I. Destruction of B16 melanoma cells mediated by bystander cytolysis in vitro.
Shiohara T; Ruddle NH; Horowitz M; Moellmann GE; Lerner AB
J Immunol; 1987 Mar; 138(6):1971-8. PubMed ID: 3102609
[TBL] [Abstract][Full Text] [Related]
7. Differential requirement for protein synthesis in cytolysis mediated by class I and class II MHC-restricted cytotoxic T cells.
Tite JP
Immunology; 1990 Aug; 70(4):440-5. PubMed ID: 2118476
[TBL] [Abstract][Full Text] [Related]
8. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T helper cell response is required for memory in CD8+ T lymphocytes induced by a poly(I:C)-adjuvanted MHC I-restricted peptide epitope.
Qiu F; Cui Z
J Immunother; 2007; 30(2):180-9. PubMed ID: 17471165
[TBL] [Abstract][Full Text] [Related]
10. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
11. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
12. Tumor growth in vivo selects for resistance to tumor necrosis factor.
Lattime EC; Stutman O
J Immunol; 1989 Dec; 143(12):4317-23. PubMed ID: 2592776
[TBL] [Abstract][Full Text] [Related]
13. CD4+ T cell-mediated killing of major histocompatibility complex class II-positive antigen-presenting cells (APC). III. CD4+ cytotoxic T cells induce apoptosis of APC.
Grogg D; Hahn S; Erb P
Eur J Immunol; 1992 Jan; 22(1):267-72. PubMed ID: 1346113
[TBL] [Abstract][Full Text] [Related]
14. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
15. Characterization of cloned class I MHC-restricted, CD8+ anti-Meth A cytotoxic T-lymphocytes: recognition of an epitope derived from the Meth A gp110 tumor rejection antigen.
Fassanito MA; Loftus D; De Leo RM; Law LW; Appella E; De Leo AB
Cancer Res; 1994 Aug; 54(16):4424-9. PubMed ID: 7519121
[TBL] [Abstract][Full Text] [Related]
16. Elevated temperature regulates tumor necrosis factor-mediated immune killing.
Gromkowski SH; Yagi J; Janeway CA
Eur J Immunol; 1989 Sep; 19(9):1709-14. PubMed ID: 2792186
[TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype.
Patel SS; Thiele DL; Lipsky PE
J Immunol; 1987 Dec; 139(11):3886-95. PubMed ID: 3500232
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
19. Class II antigen-specific murine cytolytic T lymphocytes (CTL). II. Genuine class II specificity of Lyt-2+ CTL clones.
Shinohara N; Hozumi N; Watanabe M; Bluestone JA; Johnson-Leva R; Sachs DH
J Immunol; 1988 Jan; 140(1):30-6. PubMed ID: 3257229
[TBL] [Abstract][Full Text] [Related]
20. Predominance of MHC class II-restricted CD4+ cytotoxic T cells against mouse hepatitis virus A59.
Heemskerk MH; Schoemaker HM; Spaan WJ; Boog CJ
Immunology; 1995 Apr; 84(4):521-7. PubMed ID: 7790024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
